Episode Details

Back to Episodes
Episode 224: ASCO GU 2023: discussing miR371 for Germ Cell Tumors with Christian Kollmannsberger

Episode 224: ASCO GU 2023: discussing miR371 for Germ Cell Tumors with Christian Kollmannsberger

Season 2 Episode 224 Published 3 years, 8 months ago
Description

The Uromigos are joined by Christian Kollmannsberger, MD, FRCPC, to discuss his presentation at the ASCO GU Cancers Symposium on utilizing miR371 as a biomarker for germ cell tumors to help optimize patient management by improving decision-making. Dr. Kollmannsberger is a medical oncologist at the British Columbia Cancer Agency Vancouver Cancer Centre, and Clinical Professor at the University of British Columbia.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us